Survival statistics from the incident cases of the Vaud Cancer Registry over the period 1974-1980 were computed on the basis of an active follow-up based on verification of vital status as to December 31, 1984. Product-moment crude and relative 5 to 10 year rates are presented in separate strata of sex, age and area of residence (urban or rural). Most of the rates are comparable with those in other published series from North America or Europe, but survival from gastric cancer (24% 5-year relative rates) tended to be higher, and that from bladder cancer (about 30%) lower than in most other datasets. No significant difference in survival emerged according to residence in urban Lausanne vs surrounding (rural) areas. Interesting indications ac...
Swiss national cancer mortality statistics from 1951 to 1984 and survival rates from the Vaud Cancer...
We analysed data from 49 cancer registries in 18 European countries over the period 1988- 1999 to de...
International audienceWe present the main results of the first population-based cancers survival stu...
Survival statistics from the incident cases of the Vaud Cancer Registry over the period 1974-1980 we...
Survival rates from the Vaud Cancer Registry were compared for incident cases registered in 1974-197...
Background Analysis of trends in cancer survival in defined well surveilled populations can provide ...
BACKGROUND: Analysis of trends in cancer survival in defined well surveilled populations can provide...
Data and statistics are presented on cancer death certification in Switzerland in 1990-1994, updatin...
BACKGROUND: Comparing incidence of and mortality from cancer within a given population yields severa...
International audienceEUROCARE-4 analysed about three million adult cancer cases from 82 cancer regi...
EUROCARE-4 analysed about three million adult cancer cases from 82 cancer registries in 23 European ...
Background: Comparing incidence of and mortality from cancer within a given population yields severa...
Background: The Global Burden of Disease 2000 (GBD 2000) study starts from an analysis of the overal...
Swiss national cancer mortality statistics from 1951 to 1984 and survival rates from the Vaud Cancer...
Estimates have recently been made of the incidence of cancers in the countries of the European Commu...
Swiss national cancer mortality statistics from 1951 to 1984 and survival rates from the Vaud Cancer...
We analysed data from 49 cancer registries in 18 European countries over the period 1988- 1999 to de...
International audienceWe present the main results of the first population-based cancers survival stu...
Survival statistics from the incident cases of the Vaud Cancer Registry over the period 1974-1980 we...
Survival rates from the Vaud Cancer Registry were compared for incident cases registered in 1974-197...
Background Analysis of trends in cancer survival in defined well surveilled populations can provide ...
BACKGROUND: Analysis of trends in cancer survival in defined well surveilled populations can provide...
Data and statistics are presented on cancer death certification in Switzerland in 1990-1994, updatin...
BACKGROUND: Comparing incidence of and mortality from cancer within a given population yields severa...
International audienceEUROCARE-4 analysed about three million adult cancer cases from 82 cancer regi...
EUROCARE-4 analysed about three million adult cancer cases from 82 cancer registries in 23 European ...
Background: Comparing incidence of and mortality from cancer within a given population yields severa...
Background: The Global Burden of Disease 2000 (GBD 2000) study starts from an analysis of the overal...
Swiss national cancer mortality statistics from 1951 to 1984 and survival rates from the Vaud Cancer...
Estimates have recently been made of the incidence of cancers in the countries of the European Commu...
Swiss national cancer mortality statistics from 1951 to 1984 and survival rates from the Vaud Cancer...
We analysed data from 49 cancer registries in 18 European countries over the period 1988- 1999 to de...
International audienceWe present the main results of the first population-based cancers survival stu...